Boothbay Fund Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.36M | Buy |
103,267
+38,109
| +58% | +$1.24M | 0.07% | 270 |
|
|
2025
Q1 | $2.46M | Buy |
+65,158
| New | +$2.46M | 0.06% | 293 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1610 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1638 |
|
|
2023
Q4 | – | Sell |
-27,919
| Closed | -$1.42M | – | 1709 |
|
|
2023
Q3 | $1.42M | Buy |
27,919
+2,575
| +10% | +$131K | 0.03% | 503 |
|
|
2023
Q2 | $1.27M | Sell |
25,344
-15,333
| -38% | -$766K | 0.03% | 601 |
|
|
2023
Q1 | $1.52M | Sell |
40,677
-5,258
| -11% | -$197K | 0.03% | 663 |
|
|
2022
Q4 | $2.2M | Buy |
+45,935
| New | +$2.2M | 0.05% | 463 |
|
|
2022
Q3 | – | Sell |
-22,733
| Closed | -$495K | – | 2208 |
|
|
2022
Q2 | $495K | Sell |
22,733
-7,636
| -25% | -$166K | 0.01% | 1031 |
|
|
2022
Q1 | $733K | Buy |
30,369
+689
| +2% | +$16.6K | 0.02% | 870 |
|
|
2021
Q4 | $706K | Hold |
29,680
| – | – | 0.02% | 762 |
|
|
2021
Q3 | $753K | Sell |
29,680
-19,441
| -40% | -$493K | 0.02% | 727 |
|
|
2021
Q2 | $1.11M | Sell |
49,121
-5,810
| -11% | -$131K | 0.04% | 552 |
|
|
2021
Q1 | $1.09M | Buy |
54,931
+25,719
| +88% | +$508K | 0.04% | 447 |
|
|
2020
Q4 | $776K | Buy |
+29,212
| New | +$776K | 0.03% | 481 |
|
|
2020
Q3 | – | Sell |
-17,637
| Closed | -$558K | – | 1056 |
|
|
2020
Q2 | $558K | Buy |
+17,637
| New | +$558K | 0.04% | 458 |
|